nach oben

Erschienen in:

01.01.2009 | Epidemiology

Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer

verfasst von: Søren Christensen, Robert Zachariae, Anders Bonde Jensen, Michael Væth, Susanne Møller, Joan Ravnsbæk, Hans von der Maase

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Background Elevated levels of depressive symptoms are generally found among cancer patients, but results from existing studies vary considerably with respect to prevalence and proposed risk factors. Purpose To study the prevalence of depressive symptoms and major depression 3–4 months following surgery for breast cancer, and to identify clinical risk factors while adjusting for pre-cancer sociodemographic factors, comorbidity, and psychiatric history. Patients and methods The study cohort consists of 4917 Danish women, aged 18–70 years, receiving standardized treatment for early stage invasive breast cancer during the 2 1/2 year study period. Of these, 3343 women (68%) participated in a questionnaire study 12–16 weeks following surgery. Depressive symptoms (Beck’s Depression Inventory II) and health-related behaviors were assessed by questionnaire. The Danish Breast Cancer Cooperative Group (DBCG) and the surgical departments provided disease-, treatment-, and comorbidity data for the study cohort. Information concerning sociodemographics and psychiatric history were obtained from national longitudinal registries. Results The results indicated an increased prevalence of depressive symptoms and major depression (13.7%) compared to population-based samples. The pre-cancer variables: Social status, net-wealth, ethnicity, comorbidity, psychiatric history, and age were all independent risk factors for depressive symptoms. Of the clinical variables, only nodal status carried additional prognostic information. Physical functioning, smoking, alcohol use, and BMI were also independently associated with depressive symptoms. Conclusion Risk factors for depressive symptoms were primarily restricted to pre-cancer conditions rather than disease-specific conditions. Special attention should be given to socio-economically deprived women with a history of somatic- and psychiatric disease and poor health behaviors.

Massie NJ, Popkin MK (1998) Depressive disorders. In: Holland J (ed) Psycho-oncology. Oxford University Press, New York

Al Ghazal SK, Sully L, Fallowfield L et al (2000) The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol 26:17–19PubMedCrossRef

Maraste R, Brandt L, Olsson H et al (1992) Anxiety and depression in breast-cancer patients at start of adjuvant radiotherapy—relations to age and type of surgery. Acta Oncol 31:641–643PubMedCrossRef

Gaston-Johansson F, Fall-Dickson JM, Bakos AB et al (1999) Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract 7:240–247PubMedCrossRef

Gross JJ, Carstensen LL, Pasupathi M et al (1997) Emotion and aging: experience, expression, and control. Psychol Aging 12:590–599PubMedCrossRef

Charles ST, Reynolds CA, Gatz M (2001) Age-related differences and change in positive and negative affect over 23 years. J Pers Soc Psychol 80:136–151PubMedCrossRef

Mosher CE, Danoff-Burg S (2005) A review of age differences in psychological adjustment to breast cancer. J Psychosoc Oncol 23:101–114PubMedCrossRef

Dean C (1987) Psychiatric morbidity following mastectomy—preoperative predictors and types of illness. J Psychosom Res 31:385–392PubMedCrossRef

Bloom JR (1982) Social support, accommodation to stress and adjustment to breast-cancer. Soc Sci Med 16:1329–1338PubMedCrossRef

10.

Deshields T, Tibbs T, Fan MY et al (2006) Differences in patterns of depression after treatment for breast cancer. Psychooncology 15:398–406PubMedCrossRef

11.

Pinder KL, Ramirez AJ, Black ME et al (1993) Psychiatric-disorder in patients with advanced breast-cancer—prevalence and associated factors. Eur J Cancer 29A:524–527PubMed

12.

Spitzer RL, Williams JBW, Gibbon M et al (1992) The structured clinical interview for Dsm-Iii-R (Scid).1. History, rationale, and description. Arch Gen Psychiatry 49:624–629PubMed

13.

First MB, Gibbon M, Spitzer RL (1996) Structured clinical interview for DSM-IV (IP). New York, Biometrics research department, New York State Psychiatric Institute.

14.

Radlof LS (1977) The CES-D Scale: A self-report depression scale for research in the general population. J Applied Psychol Meas 1:385–401CrossRef

15.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef

16.

Beck AT, Erbaugh J, Ward CH et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed

17.

Beck AT, Steer RA, Brown GK (1996) Manual: Beck depression inventory, 2nd edn. The Psychological Corp Hartcourt & Brace, San Antonio, TX

18.

Wilcox H, Field T (1998) Correlations between the BDI and CES-D in a sample of adolescent mothers. Adolescence 33:565–574PubMed

19.

Berard RMF, Boermeester F, Viljoen G (1998) Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management. Psychooncology 7:112–120PubMedCrossRef

20.

Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46:437–443PubMedCrossRef

21.

Hall A, A’Hern R, Fallowfield L (1999) Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?. Eur J Cancer 35:79–85PubMedCrossRef

22.

Groenvold M, Fayers PM, Sprangers MAG et al (1999) Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: A valid comparison? J Clin Epidemiol 52:523–530PubMedCrossRef

23.

Love AW, Grabsch B, Clarke DM et al (2004) Screening for depression in women with metastatic breast cancer: a comparison of the Beck depression inventory short form and the hospital anxiety and depression scale. Aust N Z J Psychiatry 38:526–531PubMedCrossRef

24.

Love AW, Kissane DW, Bloch S et al (2002) Diagnostic efficiency of the Hospital Anxiety and Depression Scale in women with early stage breast cancer. Aust N Z J Psychiatry 36:246–250PubMedCrossRef

25.

Farragher B (1998) Psychiatric morbidity following the diagnosis and treatment of early breast cancer. Ir J Med Sci 167:166–169PubMedCrossRef

26.

Pasacreta JV (1997) Depressive phenomena, physical symptom distress, and functional status among women with breast cancer. Nurs Res 46:214–221PubMedCrossRef

27.

Al Ghazal SK, Fallowfield L, Blamey RW (2000) Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer 36:1938–1943PubMedCrossRef

28.

Cordova MJ, Cunningham LLC, Carlson CR et al (2001) Posttraumatic growth following breast cancer: a controlled comparison study. Health Psychol 20:176–185PubMedCrossRef

29.

Yeter K, Rock CL, Pakiz B et al (2006) Depressive symptoms, eating psychopathology, and physical activity in obese breast cancer survivors. Psychooncology 15:453–462PubMedCrossRef

30.

Burgess C, Cornelius V, Love S et al (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. Br Med J 330:702–705CrossRef

31.

Goldberg JA, Scott RN, Davidson PM et al (1992) Psychological morbidity in the 1st year after breast surgery. Eur J Surg Oncol 18:327–331PubMed

32.

Rijken M, de Kruif AT, Komproe IH et al (1995) Depressive symptomatology of post-menopausal breast cancer patients: a comparison of women recently treated by mastectomy or by breast-conserving therapy. Eur J Surg Oncol 21:498–503PubMedCrossRef

33.

Andersen BL, Kiecoltglaser JK, Glaser R (1994) A Biobehavioral Model of Cancer Stress and Disease Course. Am Psychol 49:389–404PubMedCrossRef

34.

Andersen BL, Shapiro CL, Farrar WB et al (2005) Psychological responses to cancer recurrence—a controlled prospective study. Cancer 104:1540–1547PubMedCrossRef

35.

Antoni MH, Lehman JM, Kilbourn KM et al (2001) Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 20:20–32PubMedCrossRef

36.

Green BL, Krupnick JL, Rowland JH et al (2000) Trauma history as a predictor of psychologic symptoms in women with breast cancer. J Clin Oncol 18:1084–1093PubMed

37.

Hopwood P, Howell A, Maguire P (1991) Psychiatric morbidity in patients with advanced cancer of the breast—prevalence measured by 2 self-rating questionnaires. Br J Cancer 64:349–352PubMed

38.

vantSpijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59:280–293

39.

Aragona M, Muscatello MRA, Mesiti M (1997) Depressive mood disorders in patients with operable breast cancer. J Exp Clin Canc Res 16:111–118

40.

Ell K, Sanchez K, Vourlekis B, Lee PJ et al (2005) Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 23:3052–3060PubMedCrossRef

41.

Bardwell WA, Natarajan L, Dimsdale JE et al (2006) Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 24:2420–2427PubMedCrossRef

42.

Kissane DW, Clarke DM, Ikin J et al (1998) Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. Med J Aust 169:192–196PubMed

43.

Aukst-Margetic B, Jakovljevic M, Margetic B et al (2005) Religiosity, depression and pain in patients with breast cancer. Gen Hosp Psychiatry 27:250–255PubMedCrossRef

44.

Fallowfield LJ, Hall A, Maguire GP et al (1990) Psychological outcomes of different treatment policies in women with early breast-cancer outside a clinical-trial. Br Med J 301:575–580

45.

Lasry JCM, Margolese RG, Poisson R et al (1987) Depression and body-image following mastectomy and lumpectomy. J Chronic Dis 40:529–534PubMedCrossRef

46.

Duffy LS, Greenberg DB, Younger J et al (1999) Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients. Psychosomatics 40:304–308PubMed

47.

Cathcart CK, Jones SE, Pumroy CS et al (1993) Clinical recognition and management of depression in node-negative breast-cancer patients treated with Tamoxifen. Breast Cancer Res Treat 27:277–281PubMedCrossRef

48.

Kissane DW, Grabsch B, Love A et al (2004) Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry 38:320–326PubMedCrossRef

49.

Day R, Ganz PA, Costantino JP (2001) Tamoxifen and depression: More evidence from the National Surgical Adjuvant Breast and Bowel Project’s Breast Cancer Prevention (P-1) randomized study. J Natl Cancer Inst 93:1615–1623PubMedCrossRef

50.

Lee KC, Ray GT, Hunkeler EM et al (2007) Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics 48:205–210PubMedCrossRef

51.

Tjemsland L, Soreide JA, Malt UF (1995) Psychosocial factors in women with operable breast-cancer—an association to estrogen-receptor status. J Psychosom Res 39:875–881PubMedCrossRef

52.

Stommel M, Kurtz ME, Kurtz JC et al (2004) A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol 23:564–573PubMedCrossRef

53.

Krishnan L, Stanton AL, Collins CA et al (2001) Form or function? Part 2. Objective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer 91:2282–2287

54.

Werrij MQ, Mulkens S, Hospers HJ et al (2006) Overweight and obesity: the significance of a depressed mood. Patient Educ Couns 62:126–131PubMedCrossRef

55.

Extermann M (2000) Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 35:181–200PubMedCrossRef

56.

Janssen-Heijnen MLG, Houterman S, Lemmens VEPP et al (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55:231–240PubMedCrossRef

57.

Evans DL, Charney DS, Lewis L et al (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58:175–189PubMedCrossRef

58.

Krishnan KRR, Delong M, Kraemer H et al (2002) Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry 52:559–588PubMedCrossRef

59.

Louwman WJ, Janssen-Heijnen MLG, Houterman S et al (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41:779–785PubMedCrossRef

60.

Singletary SE, Allred C, Ashley P et al (2002) Revision of the American joint committee on cancer staging system for breast cancer. J Clin Oncol 20:3628–3636PubMedCrossRef

61.

Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef

62.

Bjørner JB, Damsgaard MT, Watt T et al (1997) Dansk manual for SF-36 (Danish manual for the SF-36), Lægemiddelindustriforeningen, Copenhagen.

63.

Ware JE, Sherbourne CD (1992) The Mos 36-item short-form health survey (Sf-36) .1. Conceptual-Framework and Item Selection. Med Care 30:473–483PubMedCrossRef

64.

World Health Organization (2000) Obesity. Preventing and managing the global endemic. Technical report series no 894, WHO, Geneva.

65.

Extermann M (2000) Measuring comorbidity in older cancer patients. Eur J Cancer 36:453–471PubMedCrossRef

66.

Rostgaard K, Holst H, Mouridsen HT et al (2000) Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 11:669–674PubMedCrossRef

67.

Statistics Denmark (2005). Statistics Denmark. Numbers on time. http://www.dst.dk/HomeUK/About/introSD.aspx. Cited 23 nov 2007

68.

UNESCO (2006) ISCED 1997. International standard classification of education, Re-edition. http://www.uis.unesco.org/TEMPLATE/pdf/isced/ISCED_A.pdf. Cited 11 oct 2007.

69.

Munk-Jorgensen P, Mortensen PB (1997) The Danish Psychiatric Central Register. Dan Med Bull 44:82–84PubMed

70.

Schafer JL, Graham JW (2002) Missing data: our view of the state of the art. Psychol Methods 7:147–177PubMedCrossRef

71.

Zachariae R, Zachariae C, Ibsen HHW et al (2004) Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol 84:205–212PubMedCrossRef

72.

Thomsen DK, Mehlsen MY, Viidik A et al (2005) Age and gender differences in negative affect—Is there a role for emotion regulation? Personality and Individual Differences 38:1935–1946CrossRef

73.

Olsen LR, Mortensen EL, Bech P (2004) Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand 109:96–103PubMedCrossRef

74.

Kessler RC, Berglund P, Demler O et al (2003) The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095–3105PubMedCrossRef

Titel: Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer
verfasst von: Søren Christensen
Robert Zachariae
Anders Bonde Jensen
Michael Væth
Susanne Møller
Joan Ravnsbæk
Hans von der Maase
Publikationsdatum: 01.01.2009
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 2/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-008-9920-9

Springer Medizin

Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2009

Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial

Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility

Integrated gene expression profile predicts prognosis of breast cancer patients

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome

TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

Pooled analysis of diarrhea events in patients with cancer treated with lapatinib

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie